Clinical analysis of chemotherapy-related anemia in non-small cell lung cancer patients
Keywords:
Non-small cell lung cancer, Chemotherapy, Anemia
Abstract
The objective is to analyze the clinical features and factors of non-small cell lung cancer patients with chemotherapy-related anemia to prevent and treat anemia. 78 cases of hospitalized patients with advanced non-small cell lung cancer treated with chemotherapy from January 2008 to October 2014 were recruited as subjects. The anemia information after chemotherapy was analyzed to understand the clinical features and the factors of anemia after chemotherapy. The incidence of anemia after chemotherapy was 82.05%, while the rate moderate and severe anemia was 34.61%. No significant difference was observed from the incidence of anemia after chemotherapy in patients in terms of gender. Among the stage IV patients, patients with bone metastasis has higher incidence of anemia after chemotherapy when compared with patients without bone metastasis (P < 0.05). Non-small cell lung cancer has a higher incidence of anemia after chemotherapy, patients should be given attention on the anemia therapy in addition to other clinical treatment. Patients with bone metastases are more prone to have anemia after chemotherapy thus, early intervention should be taken to reduce the incidence of anemia.References
1. Glaspy J, Cavill I．Role of iron in optimizing responses of anemic cancer patients to erythropoietin．Oncology 1999; 13(4): 461–473.
2. Crawford J, Kosmidis PA. Targeting anemia in patients with lung cancer. J Thoracic Oncol 2006; (7): 716–725.
3. Tamasi L, Muller, Eszer N, Kardos T, Budai M, et al. Patters of erythropoiesis stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis. Exp Opin Drug Saf, 2011; 10(4): 503–507. doi: 10.1517/14740338.2011.571200.
4. Gillespie TW. Anemia in cancer: Therapeutic implications and interventions. Cancer Nurs 2003; 26(2): 119–130. doi: 10.1097/00002820–200304000–00005.
2. Crawford J, Kosmidis PA. Targeting anemia in patients with lung cancer. J Thoracic Oncol 2006; (7): 716–725.
3. Tamasi L, Muller, Eszer N, Kardos T, Budai M, et al. Patters of erythropoiesis stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis. Exp Opin Drug Saf, 2011; 10(4): 503–507. doi: 10.1517/14740338.2011.571200.
4. Gillespie TW. Anemia in cancer: Therapeutic implications and interventions. Cancer Nurs 2003; 26(2): 119–130. doi: 10.1097/00002820–200304000–00005.
Published
2018-03-19
Issue
Section
Original Research Article
Copyright (c) 2016 Cheng Xiaofei, Tang Jiying
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
